Uncategorized

A new startup proposed by team BacCheck aims to bring to market a topical ointment using a microbiome modulation with CRISPR technology to combat anti-biotic resistant bacteria such as Methicillin-resistant Staphylococcus aureus commonly known as MRSA. The cross-faculty team met at the Proteus Innovation Competition launch event and decided to team up to develop a commercialization plan for technology offered up by Western.

Proteus is an intense, four-month competition that takes three newly developed technologies from Ontario research institutions and challenges teams to plan their commercialization. It is a partnership among WORLDiscoveries, Western Entrepreneurship, Western Research Parks, TechAlliance, McMaster University and the University of Windsor.

If ever you needed to visualize the convergence of research, clinical experience and commercialization, take a close look at the Abilex device – and its inventor.

A deceptively simple-looking hand-held instrument, the Abilex helps exercise and strengthen the jaw, tongue and mouth for people who have difficulty swallowing or speaking. It is the brainchild of Ruth Martin, Associate Dean for Graduate and Postdoctoral Programs in the Faculty of Health Sciences.

On Sept. 19, Martin will receive the Vanguard Awards Innovator of the Year honour from WORLDiscoveries for commercialization and entrepreneurship involved in developing the Abilex.